Skip to main content
Fig. 3 | BMC Surgery

Fig. 3

From: Preoperative aspartate aminotransferase to albumin ratio correlates with tumor characteristics and predicts outcome of hepatocellular carcinoma patients after curative hepatectomy: a multicenter study

Fig. 3

Kaplan–Meier estimates of survival by AAR in the primary and validation cohorts. A and B In the primary cohort, HCC patients in the high-risk group had worst prognosis in terms of RFS, whereas those in the low-risk group had best prognosis. A higher risk score was correlated with worse prognosis. C and D In the validation cohort, AAR (> 1.6, 0.7–1.6, and < 0.7) performed well in stratifying patients with distinguished prognosis. RFS recurrence-free survival, OS overall survival

Back to article page